| Literature DB >> 30806611 |
Ella M Meumann1,2, Nicholas M Anstey1,2, Bart J Currie1,2, Kim A Piera1, Johanna J Kenyon3, Ruth M Hall4, Joshua S Davis1,5, Derek S Sarovich1,6.
Abstract
Acinetobacter baumannii causes severe, fulminant, community-acquired pneumonia (CAP) in tropical and subtropical regions. We compared the population structure, virulence and antimicrobial resistance determinants of northern Australian community-onset A. baumannii strains with local and global strains. We performed whole-genome sequencing on 55 clinical and five throat colonization A. baumannii isolates collected in northern Australia between 1994 and 2016. Clinical isolates included CAP (n=41), healthcare-associated pneumonia (n=7) and nosocomial bloodstream (n=7) isolates. We also included 93 publicly available international A. baumannii genome sequences in the analyses. Patients with A. baumannii CAP were almost all critically unwell; 82 % required intensive care unit admission and 18 % died during their inpatient stay. Whole-genome phylogenetic analysis demonstrated that community-onset strains were not phylogenetically distinct from nosocomial strains. Some non-multidrug-resistant local strains were closely related to multidrug-resistant strains from geographically distant locations. Pasteur sequence type (ST)10 was the dominant ST and accounted for 31/60 (52 %) northern Australian strains; the remainder belonged to a diverse range of STs. The most recent common ancestor for ST10 was estimated to have occurred in 1738 (95 % highest posterior density, 1626-1826), with evidence of multiple introduction events between Australia and Southeast Asia between then and the present day. Virulence genes associated with biofilm formation and the type 6 secretion system (T6SS) were absent in many strains, and were not associated with in-hospital mortality. All strains were susceptible to gentamicin and meropenem; none carried an AbaR resistance island. Our results suggest that international dissemination of A. baumannii is occurring in the community on a contemporary timescale. Genes associated with biofilm formation and the T6SS may not be required for survival in community niches. The relative contributions of host and bacterial factors to the clinical severity of community-onset A. baumannii infection require further investigation.Entities:
Keywords: Acinetobacter baumannii; antimicrobial resistance; community-acquired pneumonia; epidemiology; virulence; whole-genome sequencing
Mesh:
Substances:
Year: 2019 PMID: 30806611 PMCID: PMC6487312 DOI: 10.1099/mgen.0.000258
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Demographics and severity indicators for CAP, HCAP and nosocomial BSI episodes
| CAP ( | HCAP ( | Nosocomial BSI ( |
| |
|---|---|---|---|---|
| Median age (years), (range) | 45.6 (29.8–68.8) | 42.1 (31.1–48.5) | 51.5 (41.2–76.1) | 0.11 |
| Male sex | 18/39 (46 %) | 4/7 (57 %) | 2/7 (29 %) | 0.55 |
| Indigenous | 33/36 (92 %) | 7/7 (100 %) | 6/6 (100 %) | 1.0 |
| Hazardous alcohol consumption | 25/32 (78 %) | 6/6 (100 %) | 2/6 (33 %) | 0.03 |
| ICU admission | 28/34 (82 %) | 5/7 (71 %) | 3/6 (50 %) | 0.14 |
| Inpatient death | 7/40 (18 %) | 1/7 (14 %) | 2/7 (29 %) | 0.84 |
Outcomes of infection in the presence and absence of putative virulence attributes
Fisher's exact test P-values were >0.05 for all comparisons
| Attribute (ST or virulence factor) present (+) or absent (–) | ICU admission | Died | |
|---|---|---|---|
| ST10 | + | 21/28 (75 %) | 5/31 (16 %) |
| − | 15/19 (79 %) | 5/23 (22 %) | |
|
| + | 23/30 (77 %) | 8/37 (22 %) |
| − | 13/17 (76 %) | 2/17 (12 %) | |
|
| + | 14/17 (82 %) | 4/20 (20 %) |
| − | 22/30 (73 %) | 6/34 (18 %) | |
|
| + | 9/11 (82 %) | 5/15 (33 %) |
| − | 27/36 (75 %) | 5/39 (13 %) | |
|
| + | 15/19 (79 %) | 4/22 (18 %) |
| − | 21/28 (75 %) | 6/32 (19 %) | |
| T6SS | + | 18/24 (75 %) | 7/30 (23 %) |
| − | 18/23 (78 %) | 3/24 (13 %) | |
Fig. 1.Maximum-parsimony phylogenetic analysis including Australian study and global isolates.
Fig. 2.Maximum-parsimony phylogenetic analysis of ST10 strains. (a) International and Australian isolates separated by <100 SNPs are highlighted. (b) Local Australian genomic clusters are highlighted, and the range of SNP distances between isolates in each cluster is listed.
Fig. 3.Bayesian phylogenetic analysis of ST10 strains. Blue bars indicate 95% HPD. Branch labels indicate posterior probabilities. Timescale indicated in years.
Fig. 4.Virulence genes, and onset and outcomes of infection.
Fig. 5.Phenotypic antimicrobial susceptibilities and antimicrobial resistance genes.